William Blair Initiates Coverage On Edgewise Therapeutics with Outperform Rating

William Blair analyst Alethia Young has initiated coverage on Edgewise Therapeutics (NASDAQ: EWTX) with an Outperform rating. This marks a positive outlook for the company in the market.